See discussions, stats, and author profiles for this publication at: https://www.researchgate.

net/publication/321936837

CPG Management of Dengue Infection in Adults (3rd Edition)

Book · December 2015

CITATIONS READS

0 7,461

1 author:

Hanin Kamaruzaman
Malaysian Health Technology Assessment Section (MaHTAS)
30 PUBLICATIONS   40 CITATIONS   

SEE PROFILE

Some of the authors of this publication are also working on these related projects:

HTA/TR View project

EFFECTIVENESS OF BONE TARGETING AGENTS IN PREVENTING SKELETAL RELATED EVENTS FOR METASTATIC CANCERS OF SOLID TUMOUR AND ECONOMIC
EVALUATION View project

All content following this page was uploaded by Hanin Kamaruzaman on 20 December 2017.

The user has requested enhancement of the downloaded file.

QUICK REFERENCE FOR HEALTHCARE PROVIDERS MANAGEMENT OF DENGUE INFECTION IN ADULTS (THIRD EDITION)

KEY MESSAGES

1. Dengue infection is a systemic and dynamic disease with clinical, haematological

and serological profiles changing from day to day.
2. Clinical deterioration may occur in the critical phase and is marked by plasma
leakage and rising haematocrit (HCT).
3. Look out for warning signs which may indicate severe dengue.
4. Recognition of shock in its early stage and prompt fluid therapy with close
monitoring of fluid adjustment may give a good clinical outcome.

DENGUE CASES NOTIFICATION

• All suspected dengue cases must be notified (telephone/fax/e-notification) to

the nearest health office within 24 hours of diagnosis, followed by the written
standard notification format.
• Update the notification when there is change in disease severity or dengue death.

LABORATORY INTERPRETATION

• The median HCT level among Malaysian population is taken as:

ͦ male < 60 years – 46% ͦ male > 60 years – 42%
ͦ female (all age groups) – 40%
• In the absence of baseline HCT, a HCT value higher than the above should
raise the suspicion of plasma leakage.
• Usually, leucopaenia preceeds thrombocytopaenia.

DENGUE SEROLOGY TESTS

• Rapid combo test (dengue NS1 antigen/dengue IgM/IgG antibodies) should

be done as a screening tool in suspected dengue infection and results can be
obtained within 15-20 minutes.
• Dengue non-structural protein-1 (NS1 Antigen) is helpful in early phase (< day
5) of dengue infection and usually becomes undetectable in the convalescence
phase.
• Real time reverse transcriptase polymerase chain reaction (RT-PCR) should
be done in clinically suspected seronegative patients and also in seropositive
severe dengue infection (serotyping).

DENGUE CLASSIFICATION & LEVEL OF SEVERITY

1
QUICK REFERENCE FOR HEALTHCARE PROVIDERS MANAGEMENT OF DENGUE INFECTION IN ADULTS (THIRD EDITION)

APPROACH TO OUTPATIENT EVALUATION OF DENGUE INFECTION

Overall assessment

1. History
• Date of onset of fever/illness
• Oral intake
• Assess for warning signs
• Change in mental state/seizure/dizziness
• Urine output (frequency, volume and time of last voiding)
• Other important relevant histories:
-- Pregnancy
-- Co-morbidities
2. Physical examination
i. Assess mental state and GCS score
ii. Assess hydration status
iii. Assess haemodynamic status
-- Skin colour (C), capillary filling time (normal <2 seconds) (C), cold/
warm extremities (T), pulse volume (V) and rate (R) - CCTVR
-- Blood pressure and pulse pressure
iv. Look out for tachypnoea/acidotic breathing/pleural effusion
v. Check for abdominal tenderness/tender liver/ascites
vi. Examine for bleeding manifestation
3. Investigation
i. FBC and HCT
ii. Point of care test for dengue infection (RCT or NS1 antigen)

Diagnosis, disease staging and severity assessment

Based on evaluations in history, physical examination ± FBC, HCT and point of care
test, the clinicians should be able to determine:
1. Likelihood of dengue infection
2. The phase of dengue infection (febrile/critical/recovery)
3. Severity of the illness

Plan of management

1. Dengue assessment checklist must be filled

2. Notify the district health office followed by disease notification form
3. If admission is indicated
• Stabilise the patient at primary care before transfer
• Communicate with the receiving hospital/Emergency Department (ED)
before transfer
• At ED, dengue patients with deteriorating vital signs must be uptriaged
accordingly
• All dengue patients requiring admission should be immediately started
on an appropriate fluid therapy (oral or IV)
• Chest X-ray and ultrasound (where available) are required in patients
suspected to have vascular leakage.
4. If admission is not indicated
• Daily follow up is necessary until the patient remains afebrile for at least
24 - 48 hours
• Provide patient with Outpatient Dengue Monitoring Record and Home
Care Advice Leaflet for Dengue Patients

2
QUICK REFERENCE FOR HEALTHCARE PROVIDERS MANAGEMENT OF DENGUE INFECTION IN ADULTS (THIRD EDITION)

DISEASE MONITORING PARAMETERS

Frequency of monitoring
Parameters for
monitoring Febrile phase Critical phase Reabsorption phase
Clinical Parameters
General well being Daily or more At least twice a day Daily or more
Appetite / oral intake frequently towards late and more frequently as frequently as
Warning signs febrile phase indicated indicated

Haemodynamic
status
• CCTVR
• BP 2-4 hourly depending
• Pulse pressure on clinical status
Respiratory status 4-6 hourly depending
• RR on clinical status In shock 4-6 hourly
• SpO2 Every 15-30 minutes till
Neurological Status stable then 1-2 hourly
• Conscious level
• Restlessness
• Seizures

Urine output 4 hourly 2-4 hourly 4-6 hourly

In shock : Hourly

Parameters for Frequency of monitoring

monitoring Febrile phase Critical phase Reabsorption phase
Laboratory Parameters and Imaging
All investigations done at ED must be reviewed immediately upon ward admission
4-12 hourly depending
FBC Daily or more on clinical status Daily
In shock
frequently as indicated Repeated before and
after each fluid
resuscitation and as
indicated

BUSE/Creatinine At least daily or more

LFT + AST As clinically indicated frequently as indicated As clinically
RBS In shock indicated
Crucial to monitor ABG
Creatine Kinase
and lactate closely

ABG, lactate As clinically indicated As clinically indicated As clinically

Coagulation profile indicated
Troponin or CKMB
CRP, Fibrinogen, LDH,
Ferritin, Triglyceride
ECG, Echocardiogram
Ultrasound

COMMON PITFALLS IN FLUID THERAPY

• Treating patients with unnecessary fluid boluses based on raised HCT or warning
signs as the sole parameter without considering other clinical parameters.
• Excessive and prolonged fixed fluid regime in stable patients.
• Infrequent monitoring and adjustment of infusion rate.
• Continuation of intravenous fluid during the recovery phase.
• Excessive fluid therapy in patients with co-morbidities (such as heart disease and
renal disease).

3
QUICK REFERENCE FOR HEALTHCARE PROVIDERS MANAGEMENT OF DENGUE INFECTION IN ADULTS (THIRD EDITION)

FLUID THERAPY IN NON-SHOCK PATIENTS (DENGUE FEVER WITH WARNING SIGNS)

• In dengue patients without co-morbidities who can tolerate orally, adequate oral fluid intake
of two to three litres daily should be encouraged (often 1.2-1.5 times the normal maintenance
will be required during the critical phase).
• Frequent adjustment of maintenance fluid regime is needed during the critical phase.
• In patients with persistent warning signs with increasing or persistently high HCT, the graded
fluid bolus may be initiated with caution.

CALCULATION FOR ROUTINE MAINTENANCE INTRAVENOUS FLUID

Non-obese patients
• 1.2 to 1.5 ml/kg/hour

Obese patients (BMI >27.5 kg/m2)

• Routine maintenance fluid can be calculated based on adjusted body weight (ABW).
o ABW = IBW + 0.4 (actual weight - IBW)
o Ideal bodyweight (IBW) can be estimated based on the following formula.
Female: 45.5 kg + 0.91(height in cm -152)
Male: 50.0 kg + 0.91(height in cm -152)
CAUTION : Fluid intake and urine output must be reviewed and adjusted according to clinical response.

GRADED FLUID BOLUS REGIME IN NON-SHOCK PATIENTS (DF with Warning Signs)
• Obtain a baseline HCT before fluid therapy.
• Give crystalloids solution (such as 0.9% saline).
• Start with 5 ml/kg/hour for 1–2 hours, then reduce to 3 ml/kg/hr for 2–4 hours, and then
reduce to 2 ml/kg/hr or less according to the clinical response.
• If the clinical parameters are worsening and HCT is rising, increase the rate of infusion.
• Reassess the clinical status, repeat the HCT and review fluid infusion rates accordingly.

WHEN TO SUSPECT SIGNIFICANT OCCULT BLEEDING

Suspect significant occult bleeding in the following situations:
• HCT not as high as expected for the degree of shock to be explained by plasma leakage
alone.
• A drop in HCT without clinical improvement despite adequate fluid replacement (40-60 ml/kg).
• Severe metabolic acidosis and end-organ dysfunction despite adequate fluid replacement.

MANAGEMENT OF SIGNIFICANT BLEEDING

• Transfuse blood (5–10ml/kg of packed red cells) and observe the clinical response. Consider
blood components if required.
• Consider repeating the blood transfusion if there is further blood loss or no appropriate rise
in HCT after blood transfusion.
• Endoscopy by trained surgeon or gastroenterologist is indicated if these patients have
persistent bleeding despite optimum medical therapy.

DENGUE INFECTION IN PREGNANCY

• All pregnant mothers with dengue infection should be managed in hospitals by a
multidisciplinary team (physician, anaesthetist and obstetrician) due to a higher risk of
morbidity and mortality.
• Spontaneous vaginal delivery is the preferred mode of delivery.
• Group and cross match (GXM) must be done. Blood and blood products transfusion to be
given only when indicated or when instrumental/operative delivery is decided
• Serology test (Dengue IgM and NS1 antigen) or real time RT-PCR should be performed in
neonates when congenital dengue infection is suspected.

4
QUICK REFERENCE FOR HEALTHCARE PROVIDERS MANAGEMENT OF DENGUE INFECTION IN ADULTS (THIRD EDITION)

ALGORITHM A - FLUID MANAGEMENT IN COMPENSATED SHOCK

COMPENSATED SHOCK
(systolic pressure maintained but has signs of reduced perfusion)
• Fluid resuscitation with isotonic crystalloid 5-10 ml/kg/hr for 1 hour
• Obtain FBC, HCT, RP, LFT, RBS, PT/APTT, CK, Lactate/HCO3, GXM1 before
fluid resuscitation.

IMPROVEMENT*
YES NO

Check HCT

• IV crystalloid 5-7 ml/kg/hr for

1-2 hours, then:

reduce to 3-5 ml/kg/hr

for 2-4 hours; then

reduce to 2-3 ml/kg/hr

for 2-4 hours
HCT or high HCT
• If patient continues to
improve, fluid can be further
reduced.

• Monitor HCT 4-6 hourly. Administer 2nd bolus Consider significant

of fluid (colloid) ** occult/overt bleed
• If the patient is not stable, 10-20 ml/kg/hr for 1 hour Initiate transfusion
act according to HCT with packed red
levels: cells and/or blood
components
if HCT increases,
consider bolus
fluid administration
or increase fluid NO
administration IMPROVEMENT*

if HCT decreases,
consider transfusion YES
with packed red
cells and/or blood
components
• If patient improves, reduce to
• Consider to stop IV fluid at 7-10 ml/kg/hr for 1-2 hours
48 hours of plasma leakage/
defervescence. • Then reduce further

* Reassess the patient’s clinical condition, vital signs, pulse volume, capillary refill
time, urine output and temperature of extremities.

** Colloid is preferable if the patient has already received previous bolus of crystalloid

IV = intravenous ; HCT = haematocrit

= increased ; = decreased
1
GXM: emergency cross-match
5
QUICK REFERENCE FOR HEALTHCARE PROVIDERS MANAGEMENT OF DENGUE INFECTION IN ADULTS (THIRD EDITION)

ALGORITHM B - FLUID MANAGEMENT IN DECOMPENSATED SHOCK

DECOMPENSATED SHOCK
• Fluid resuscitation with 20 ml/kg colloid / crystalloid within 15 - 30 minutes
• Obtain HCT/FBC, RP, LFT, RBS, PT/APTT, CK, Lactate/HCO3, GXM1 before
fluid resuscitation.

IMPROVEMENT* NO
YES
Review 1 HCT
st

• Crystalloid/colloid
10ml/kg/hr for 1 hour,
then continue with:

IV crystalloid HCT or high HCT HCT unchanged

5-7 ml/kg/hr
for 1-2 hours;
then
Administer 2nd Consider REFER TO
reduce to 3-5 bolus of fluid significant ALGORITHM C
ml/kg/hr for 2-4 (colloid)^ occult/overt
hours; then 10-20 ml/kg over bleed
½ to 1 hour Initiate transfusion
reduce to 2-3
ml/kg/hr for with packed red
2-4 hours cells and /or blood
components
• If patient continues to
improve, fluid can be
further reduced.
YES
• Monitor HCT 4 hourly
or more frequent as IMPROVEMENT*
indicated. NO

• If the patient is not

stable, act according Repeat 2nd HCT
to HCT levels:

if HCT
increases,
c o n s i d e r
bolus fluid
administration HCT or high HCT
or increase fluid
administration;

if HCT Administer 3rd bolus of

decreases, fluid (colloid) 10-20 ml/kg
c o n s i d e r over 1 hour
transfusion
with packed
red cells NO
• Consider to stop Repeat IMPROVEMENT*
IV fluid at 48 hours 3rd HCT
of plasma leakage/
defervescence.
YES

* Reassess the patient’s clinical condition, vital signs, pulse volume, capillary refill time and
temperature of extremities.
^ Colloid is preferable if the patient has already received previous bolus of crystalloid.

IV = intravenous ; HCT = haematocrit

= increased ; = decreased
1
GXM: emergency cross-match
6
 ALGORITHM C - FLUID MANAGEMENT IN DECOMPENSATED SHOCK
(WITH PRESENCE OF BLEEDING & LEAKING OR OTHER CAUSES OF SHOCK)

HAEMATOCRIT REMAIN UNCHANGED AFTER FIRST FLUID RESUSCITATION

Consider other causes of shock

Bleeding and leaking at Severe metabolic acidosis

same time with hyperlactataemia (liver
+/- multiorgan failure)
Look for source of bleeding
(eg. OGDS) Vasopressor

Evidence of leaking (USG, +

chest X-ray) Supportive care
Check for coagulopathy +
Transfuse packed red cells Continuous renal replacement
and blood components therapy (CRRT)

Septic shock Cardiac dysfunction Cytokine storm

Vasodilated state Noradrenaline
and fluids
Noradrenaline
titrated to MAP Low CO : High CO : Check for disease
65 mmHg markers of
Inotrope Vasodilated shock with haemophagocytic
(eg. dobutamine/ myocardial dysfunction syndrome
adrenaline)
Inotropes +
vasopressor
(eg. noradrenaline
+ dobutamine /
adrenaline)

All the above types of shocks need to be supported by echocardiography and non-invasive cardiac
output monitoring and treatments tailor to each patient.

HCT = haematocrit ; MAP = mean arterial pressure ; CO = cardiac output;

OGDS = oesophagogastroduodenoscopy USG = ultrasonography

This Quick Reference provides key messages and a summary of the main recommendations in the
Clinical Practice Guidelines (CPG) Management of Dengue Infection in Adults 2015 (Third Edition).

Details of the evidence supporting these recommendations can be found in the above CPG,
available on the following websites:
Ministry of Health Malaysia: www.moh.gov.my
Academy of Medicine Malaysia: www.acadmed.org.my

CLINICAL PRACTICE GUIDELINES SECRETARIAT

Malaysia Health Technology Assessment Section (MaHTAS)
Medical Development Division
Ministry of Health Malaysia
4th Floor, Block E1, Parcel E, 62590 Putrajaya
Tel : +603-88831246 E-mail : [email protected]
View publication stats